Similar Items: Methodological Confounders in Evaluating Intra‐Class Therapeutic Interchange to Evogliptin: A Closer Look at the REVISE Sub‐Analysis
- Role of Evogliptin for Intra‐Class Therapeutic Interchange in Patients With Type 2 Diabetes Mellitus: Subgroup Analysis From A Multi‐Center, Prospective, Observational Study (REVISE Study)
- Platelet–Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities
- Metformin in endometrial cancer from metabolic regulation to precision therapeutics
- The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
- Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
- The role of HBV in reprogramming liver cancer stem cells and shaping their plasticity and therapeutic vulnerabilities